agilon health (NYSE:AGL) Now Covered by Analysts at Macquarie

Macquarie began coverage on shares of agilon health (NYSE:AGL - Free Report) in a research note released on Monday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $3.00 price target on the stock.

Several other equities analysts have also recently issued reports on the stock. Stifel Nicolaus dropped their target price on shares of agilon health from $7.00 to $2.00 and set a "hold" rating on the stock in a report on Tuesday, November 12th. Barclays cut their price target on shares of agilon health from $5.00 to $2.00 and set an "underweight" rating on the stock in a report on Monday, November 11th. Citigroup decreased their target price on agilon health from $2.50 to $1.75 and set a "sell" rating for the company in a research report on Wednesday, November 13th. Royal Bank of Canada reiterated an "outperform" rating and issued a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Finally, Bank of America cut shares of agilon health from a "buy" rating to an "underperform" rating and set a $3.00 target price for the company. in a research note on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, sixteen have given a hold rating and two have issued a buy rating to the company. According to MarketBeat, agilon health has an average rating of "Hold" and an average price target of $4.28.

agilon health Price Performance

AGL stock traded down $0.05 during trading on Monday, hitting $2.20. The company had a trading volume of 5,989,492 shares, compared to its average volume of 4,861,157. The firm has a market capitalization of $904.38 million, a price-to-earnings ratio of -2.38 and a beta of 0.51. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The business has a 50 day moving average of $2.44 and a 200 day moving average of $4.38. agilon health has a fifty-two week low of $1.50 and a fifty-two week high of $13.45.

agilon health (NYSE:AGL - Get Free Report) last posted its quarterly earnings data on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts' consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion for the quarter, compared to analyst estimates of $1.47 billion. agilon health had a negative net margin of 6.88% and a negative return on equity of 47.84%. During the same quarter in the prior year, the business earned ($0.06) EPS. As a group, research analysts predict that agilon health will post -0.52 earnings per share for the current year.

Insider Transactions at agilon health

In other agilon health news, Director John William Wulf purchased 45,000 shares of the company's stock in a transaction that occurred on Thursday, December 5th. The stock was purchased at an average price of $2.18 per share, with a total value of $98,100.00. Following the completion of the transaction, the director now directly owns 206,133 shares of the company's stock, valued at approximately $449,369.94. This trade represents a 27.93 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Diana Mckenzie acquired 12,500 shares of the stock in a transaction dated Monday, November 25th. The stock was bought at an average price of $2.28 per share, for a total transaction of $28,500.00. Following the completion of the purchase, the director now owns 51,319 shares in the company, valued at approximately $117,007.32. This trade represents a 32.20 % increase in their position. The disclosure for this purchase can be found here. Over the last quarter, insiders have purchased 90,000 shares of company stock worth $198,100. Insiders own 3.20% of the company's stock.

Institutional Trading of agilon health

Large investors have recently bought and sold shares of the stock. Citigroup Inc. grew its stake in agilon health by 2,251.5% during the third quarter. Citigroup Inc. now owns 2,028,246 shares of the company's stock worth $7,971,000 after buying an additional 1,941,993 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of agilon health by 3,338.5% during the second quarter. AQR Capital Management LLC now owns 1,356,438 shares of the company's stock valued at $8,871,000 after purchasing an additional 1,316,990 shares during the last quarter. Quantbot Technologies LP bought a new stake in shares of agilon health during the third quarter worth $1,742,000. Susquehanna Fundamental Investments LLC raised its holdings in agilon health by 65.0% during the 2nd quarter. Susquehanna Fundamental Investments LLC now owns 804,594 shares of the company's stock worth $5,262,000 after purchasing an additional 316,856 shares during the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund acquired a new position in agilon health during the 2nd quarter valued at about $1,849,000.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.